SCHEMBL8963676

SCHEMBL8963676

Cc1ccc(-c2nc(C(=O)CBr)c(C(C)(C)C)[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.41
PIN1 Q13526 2/20 0.38
CHEK2 O96017 2/20 0.38
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
EGFR P00533 1/20 0.36
TNKS O95271 3/20 0.36
PARP1 P09874 3/20 0.36
TNKS2 Q9H2K2 3/20 0.36
TYMP P19971 1/20 0.36
HPSE Q9Y251 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963883 0.83 IKBKB (0.47) PIN1CHEK2RAB9ASMN1; SMN2KDM4E
SCHEMBL8963842 0.78 PIN1 (0.48) PIN1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL8963571 0.72 PIN1 (0.50) GSK3BPIN1CHEK2SMN1; SMN2KDM4E
SCHEMBL8963968 0.71 PIN1 (0.69) GSK3BPIN1KDM4EMAPT
SCHEMBL8964001 0.70 PIN1 (0.51) GSK3BPIN1CHEK2RAB9ASMN1; SMN2
SCHEMBL8963710 0.70 RAB9A (0.41) CHEK2RAB9ASMN1; SMN2KDM4EMEN1
SCHEMBL8963973 0.69 PIN1 (0.58) PIN1SMN1; SMN2KDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL8963801 0.69 RAB9A (0.38) CHEK2RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL8963771 0.69 GSK3B (0.46) GSK3BCHEK2KDM4EMEN1ALDH1A1
SCHEMBL8963720 0.68 PIN1 (0.71) PIN1RAB9AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
EP-0289227-B1 SUBSTITUTED IMIDAZOLYL-ALKYL-PIPERAZINE AND -DIAZEPINE DERIVATIVES SYNTEX PHARMACEUTICALS LTD. (GB) 1992-04-08 EP disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed
EP-0289227-A1 Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS LTD. (GB) 1988-11-02 EP disclosed